Gene Therapy
Gene therapy is a 'disruptive science' ready for commercial development
Published in Gene Therapy Weekly, February 9th, 2012
2012 FEB 9 -- The time for commercial development of gene therapy has come. Patients with diseases treatable and curable with gene therapy deserve access to the technology, which has demonstrated both its effectiveness and feasibility, says James Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy in a provocative commentary and accompanying videocast. Human Gene Therapy and Human Gene Therapy (HGT) Methods are peer-reviewed journals published by Mary Ann Liebert, Inc..
Until recently, gene therapy has been reserved for severe diseases with few treatment options. But the recent report of its successful use to treat hemophilia B, which would offer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2012-02-09)
More Articles from Gene Therapy Weekly
- Gene Therapy
Study Findings on Gene Therapy Are Outlined in Reports from Beth Israel Deaconess Medical Center - Herpes Simplex Virus
Study Findings from University of Naples Provide New Insights into Herpes Simplex Virus - Lymphoma
Study Findings from Sestre Milosrdnice University Hospital Provide New Insights into Lymphoma - Colon Cancer
Study Data from Faculty of Biological Sciences Update Knowledge of Colon Cancer - Squamous Cell Carcinoma
Study Data from Chiba University Provide New Insights into Squamous Cell Carcinoma - Cancer Therapy
Study Data from Autonomous University Provide New Insights into Cancer Therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
